230 related articles for article (PubMed ID: 33274592)
1. Combined inhibition of Ref-1 and STAT3 leads to synergistic tumour inhibition in multiple cancers using 3D and in vivo tumour co-culture models.
Caston RA; Shah F; Starcher CL; Wireman R; Babb O; Grimard M; McGeown J; Armstrong L; Tong Y; Pili R; Rupert J; Zimmers TA; Elmi AN; Pollok KE; Motea EA; Kelley MR; Fishel ML
J Cell Mol Med; 2021 Jan; 25(2):784-800. PubMed ID: 33274592
[TBL] [Abstract][Full Text] [Related]
2. APE1/Ref-1 regulates STAT3 transcriptional activity and APE1/Ref-1-STAT3 dual-targeting effectively inhibits pancreatic cancer cell survival.
Cardoso AA; Jiang Y; Luo M; Reed AM; Shahda S; He Y; Maitra A; Kelley MR; Fishel ML
PLoS One; 2012; 7(10):e47462. PubMed ID: 23094050
[TBL] [Abstract][Full Text] [Related]
3. Apurinic/apyrimidinic endonuclease/redox factor-1 (APE1/Ref-1) redox function negatively regulates NRF2.
Fishel ML; Wu X; Devlin CM; Logsdon DP; Jiang Y; Luo M; He Y; Yu Z; Tong Y; Lipking KP; Maitra A; Rajeshkumar NV; Scandura G; Kelley MR; Ivan M
J Biol Chem; 2015 Jan; 290(5):3057-68. PubMed ID: 25492865
[TBL] [Abstract][Full Text] [Related]
4. Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models.
Logsdon DP; Grimard M; Luo M; Shahda S; Jiang Y; Tong Y; Yu Z; Zyromski N; Schipani E; Carta F; Supuran CT; Korc M; Ivan M; Kelley MR; Fishel ML
Mol Cancer Ther; 2016 Nov; 15(11):2722-2732. PubMed ID: 27535970
[TBL] [Abstract][Full Text] [Related]
5. Ref-1 redox activity alters cancer cell metabolism in pancreatic cancer: exploiting this novel finding as a potential target.
Gampala S; Shah F; Lu X; Moon HR; Babb O; Umesh Ganesh N; Sandusky G; Hulsey E; Armstrong L; Mosely AL; Han B; Ivan M; Yeh JJ; Kelley MR; Zhang C; Fishel ML
J Exp Clin Cancer Res; 2021 Aug; 40(1):251. PubMed ID: 34376225
[TBL] [Abstract][Full Text] [Related]
6. Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.
Gampala S; Shah F; Zhang C; Rhodes SD; Babb O; Grimard M; Wireman RS; Rad E; Calver B; Bai RY; Staedtke V; Hulsey EL; Saadatzadeh MR; Pollok KE; Tong Y; Smith AE; Clapp DW; Tee AR; Kelley MR; Fishel ML
Br J Cancer; 2021 Apr; 124(9):1566-1580. PubMed ID: 33658640
[TBL] [Abstract][Full Text] [Related]
7. Blocking HIF signaling via novel inhibitors of CA9 and APE1/Ref-1 dramatically affects pancreatic cancer cell survival.
Logsdon DP; Shah F; Carta F; Supuran CT; Kamocka M; Jacobsen MH; Sandusky GE; Kelley MR; Fishel ML
Sci Rep; 2018 Sep; 8(1):13759. PubMed ID: 30214007
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of DNA repair and redox signaling protein APE1/Ref-1 impairs human pancreatic cancer cell survival, proliferation, and cell cycle progression.
Jiang Y; Zhou S; Sandusky GE; Kelley MR; Fishel ML
Cancer Invest; 2010 Nov; 28(9):885-95. PubMed ID: 20919954
[TBL] [Abstract][Full Text] [Related]
9. Impact of APE1/Ref-1 redox inhibition on pancreatic tumor growth.
Fishel ML; Jiang Y; Rajeshkumar NV; Scandura G; Sinn AL; He Y; Shen C; Jones DR; Pollok KE; Ivan M; Maitra A; Kelley MR
Mol Cancer Ther; 2011 Sep; 10(9):1698-708. PubMed ID: 21700832
[TBL] [Abstract][Full Text] [Related]
10. In vitro and In vivo evidence demonstrating chronic absence of Ref-1 Cysteine 65 impacts Ref-1 folding configuration, redox signaling, proliferation and metastasis in pancreatic cancer.
Mijit M; Kpenu E; Chowdhury NN; Gampala S; Wireman R; Liu S; Babb O; Georgiadis MM; Wan J; Fishel ML; Kelley MR
Redox Biol; 2024 Feb; 69():102977. PubMed ID: 38056311
[TBL] [Abstract][Full Text] [Related]
11. Radiation-induced HIF-1alpha cell survival pathway is inhibited by soy isoflavones in prostate cancer cells.
Singh-Gupta V; Zhang H; Banerjee S; Kong D; Raffoul JJ; Sarkar FH; Hillman GG
Int J Cancer; 2009 Apr; 124(7):1675-84. PubMed ID: 19101986
[TBL] [Abstract][Full Text] [Related]
12. Ape1 regulates WNT/β-catenin signaling through its redox functional domain in pancreatic cancer cells.
Jiang S; Zhu L; Tang H; Zhang M; Chen Z; Fei J; Han B; Zou GM
Int J Oncol; 2015 Aug; 47(2):610-20. PubMed ID: 26081414
[TBL] [Abstract][Full Text] [Related]
13. Antitumor Activity and Mechanistic Characterization of APE1/Ref-1 Inhibitors in Bladder Cancer.
Fishel ML; Xia H; McGeown J; McIlwain DW; Elbanna M; Craft AA; Kaimakliotis HZ; Sandusky GE; Zhang C; Pili R; Kelley MR; Jerde TJ
Mol Cancer Ther; 2019 Nov; 18(11):1947-1960. PubMed ID: 31413178
[TBL] [Abstract][Full Text] [Related]
14. Activation of the integrated stress response (ISR) pathways in response to Ref-1 inhibition in human pancreatic cancer and its tumor microenvironment.
Mijit M; Boner M; Cordova RA; Gampala S; Kpenu E; Klunk AJ; Zhang C; Kelley MR; Staschke KA; Fishel ML
Front Med (Lausanne); 2023; 10():1146115. PubMed ID: 37181357
[TBL] [Abstract][Full Text] [Related]
15. Identification of Novel Pathways Regulated by APE1/Ref-1 in Human Retinal Endothelial Cells.
Mijit M; Liu S; Sishtla K; Hartman GD; Wan J; Corson TW; Kelley MR
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674619
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of apurinic/apyrimidinic endonuclease 1/redox factor-1 enhances the sensitivity of human pancreatic cancer cells to radiotherapy in vitro.
Chen S; Xiong G; Wu S; Mo J
Cancer Biother Radiopharm; 2013 Mar; 28(2):169-76. PubMed ID: 23268706
[TBL] [Abstract][Full Text] [Related]
17. Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer.
Nagathihalli NS; Castellanos JA; Shi C; Beesetty Y; Reyzer ML; Caprioli R; Chen X; Walsh AJ; Skala MC; Moses HL; Merchant NB
Gastroenterology; 2015 Dec; 149(7):1932-1943.e9. PubMed ID: 26255562
[TBL] [Abstract][Full Text] [Related]
18. Bioactivation of Napabucasin Triggers Reactive Oxygen Species-Mediated Cancer Cell Death.
Froeling FEM; Swamynathan MM; Deschênes A; Chio IIC; Brosnan E; Yao MA; Alagesan P; Lucito M; Li J; Chang AY; Trotman LC; Belleau P; Park Y; Rogoff HA; Watson JD; Tuveson DA
Clin Cancer Res; 2019 Dec; 25(23):7162-7174. PubMed ID: 31527169
[TBL] [Abstract][Full Text] [Related]
19. Suppression of choroidal neovascularization through inhibition of APE1/Ref-1 redox activity.
Li Y; Liu X; Zhou T; Kelley MR; Edwards PA; Gao H; Qiao X
Invest Ophthalmol Vis Sci; 2014 Jun; 55(7):4461-9. PubMed ID: 24970265
[TBL] [Abstract][Full Text] [Related]
20. New Ref-1/APE1 targeted inhibitors demonstrating improved potency for clinical applications in multiple cancer types.
Gampala S; Moon HR; Wireman R; Peil J; Kiran S; Mitchell DK; Brewster K; Mang H; Masters A; Bach C; Smith-Kinnamen W; Doud EH; Rai R; Mosley AL; Quinney SK; Clapp DW; Hamdouchi C; Wikel J; Zhang C; Han B; Georgiadis MM; Kelley MR; Fishel ML
Pharmacol Res; 2024 Mar; 201():107092. PubMed ID: 38311014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
